Monovalent Nanocrystals for Biomedical Imaging
Monovalent Nanocrystals for Biomedical Imaging
批准号:
7707451
负责人:
PAUL Damien ADAMS
金额:
$21.3万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2011-07-31
关键词:
AreaArkansasBiochemistryBiologicalCadmiumCollaborationsCouplingDendrimersDetectionDevelopmentDiagnosticDiseaseDyesElectronicsEvaluationFutureGoalsGoldHeavy MetalsImaging TechniquesImaging technologyIn VitroLigandsLigationMaleimidesMethodologyMethodsNitrilotriacetic AcidOrganic SynthesisPlant ResinsPolymersPreparationPrincipal InvestigatorProceduresPropertyProtein ChemistryProteinsQualifyingQuantum DotsResearchResearch PersonnelS PhaseSemiconductorsSignal TransductionSolidSpectrum AnalysisSystemTechniquesTechnologyTherapeuticToxic effectUniversitiesWaterbioimagingdesignexperienceflexibilityimprovedin vivoindium arsenidenanobiotechnologynanocrystalnanoscalenovelphysical propertyprotein foldingpublic health relevancesingle moleculestoichiometrytechnique developmentwater solubility
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Methodology is proposed to develop efficient and general procedures for the synthesis of nontoxic quantum dots, and for conjugating, or 'tagging' these dots to proteins, for the purpose of enhancing and improving biomedical imaging techniques. It is generally agreed that quantum dots (QDs) offer many advantages over organic dyes or gold nanocrystals in applications of protein tagging and other imaging technologies. Approaches to disease detection via imaging techniques require novel methods of QD conjugation to biomolecules. The proposed project involves a collaboration between Principal Investigators with expertise in organic synthesis (to prepare tailored dendrons for use in passivating and stabilizing nanocrystals), nanocrystal synthesis (to design and synthesize nontoxic nanocrystals with tunable electronic and spectroscopic properties), physical biochemistry (to demonstrate the feasibility of attachment of the designed nanocrystals to a representative protein that is involved in cell signaling), and single molecule spectroscopy (to demonstrate the ability of the designed systems to aid in the study of protein folding). The team will develop techniques to characterize previously unrealized structural and/or biological properties of nanocrystal bioconjugates in-vitro, and subsequently in-vivo. Accomplishment of the aims of this project is expected to demonstrate the advantages of bionanotechnology as a new avenue of diagnostic and therapeutic treatment. This exploratory project has 3 specific aims: 1. Synthesize, characterize, and optimize appropriately functionalized dendrons for ligation to nontoxic Mn-doped ZnSe (Mn:ZnSe d-dots) and InAs/InP/ZnS core/shell/shell near infrared (NIR) QDs. 2. Explore solid-phase synthesis strategies to prepare Mn:ZnSe d-dots that are covalently attached to polymer resins. Derivatize the quantum dots for water solubility using methoxyethylamine-capped dendrimers. 3. Functionalize the monovalent d-dots for protein conjugation via four linkers that will provide maximum potential in a wide variety of protein applications: nitrilotriacetic acid (NTA), N-hydroxysuccinimide (NHS), maleimide, and acyl hydrazide. Conjugate the d-dots with representative proteins, purify, and characterize chemically and spectroscopically.
PUBLIC HEALTH RELEVANCE: Organic dyes have been used for years in biomedical imaging applications, but they suffer from a number of limitations, many of which can be overcome by using nanometer-sized crystals (nanocrystals, also known as quantum dots). Past efforts in this area have several drawbacks, including toxicity from the heavy metal components of commercially available nanocrystalline materials, methods for the synthesis of nontoxic quantum dots, and inefficient methods for coupling quantum dots to biomolecules such as proteins. The University of Arkansas team directing this project aims to overcome these limitations, and is uniquely qualified to do so, since it comprises Principle Investigators with expertise in every aspect of the synthesis and evaluation of protein-coupled nontoxic quantum dots.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Monovalent Nanocrystals for Biomedical Imaging
-
批准号:7904025
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2009
-
负责人:PAUL Damien ADAMS
-
依托单位:
Biophysical studies of oncogenic Cdc42Hs constructs
-
批准号:7940198
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:PAUL Damien ADAMS
-
依托单位:
Biophysical studies of oncogenic Cdc42Hs constructs
-
批准号:7667244
-
项目类别:
-
资助金额:$14.05万
-
财政年份:2007
-
负责人:PAUL Damien ADAMS
-
依托单位:
Biophysical studies of oncogenic Cdc42Hs constructs
-
批准号:8103146
-
项目类别:
-
资助金额:$14.63万
-
财政年份:2007
-
负责人:PAUL Damien ADAMS
-
依托单位:
Biophysical studies of oncogenic Cdc42Hs constructs
-
批准号:7912935
-
项目类别:
-
资助金额:$14.36万
-
财政年份:2007
-
负责人:PAUL Damien ADAMS
-
依托单位:
Biophysical studies of oncogenic Cdc42Hs constructs
-
批准号:7494160
-
项目类别:
-
资助金额:$11.69万
-
财政年份:2007
-
负责人:PAUL Damien ADAMS
-
依托单位:
Biophysical studies of oncogenic Cdc42Hs constructs
-
批准号:7201874
-
项目类别:
-
资助金额:$11.36万
-
财政年份:2007
-
负责人:PAUL Damien ADAMS
-
依托单位:
PROJECT 1 - LAWRENCE BERKELEY LAB - PHENIX
-
批准号:7208309
-
项目类别:
-
资助金额:$70.88万
-
财政年份:2006
-
负责人:PAUL Damien ADAMS
-
依托单位:
PROJECT 1 - LAWRENCE BERKELEY LAB - PHENIX
-
批准号:7673541
-
项目类别:
-
资助金额:$94.68万
-
财政年份:--
-
负责人:PAUL Damien ADAMS
-
依托单位:
PROJECT 1 - LAWRENCE BERKELEY LAB - PHENIX
-
批准号:7908729
-
项目类别:
-
资助金额:$95.52万
-
财政年份:--
-
负责人:PAUL Damien ADAMS
-
依托单位:
PROJECT 1 - LAWRENCE BERKELEY LAB - PHENIX
-
批准号:7477053
-
项目类别:
-
资助金额:$93.71万
-
财政年份:--
-
负责人:PAUL Damien ADAMS
-
依托单位:
PROJECT 1 - LAWRENCE BERKELEY LAB - PHENIX
-
批准号:8137091
-
项目类别:
-
资助金额:$93.67万
-
财政年份:--
-
负责人:PAUL Damien ADAMS
-
依托单位:
海外基金